BEAM
Price
$22.54
Change
+$0.30 (+1.35%)
Updated
May 9, 6:59 PM EST
89 days until earnings call
HLVX
Price
$13.99
Change
+$0.51 (+3.78%)
Updated
May 9, 6:59 PM EST
27 days until earnings call
Ad is loading...

BEAM vs HLVX

Header iconBEAM vs HLVX Comparison
Open Charts BEAM vs HLVXBanner chart's image
Beam Therapeutics
Price$22.54
Change+$0.30 (+1.35%)
Volume$519.08K
CapitalizationN/A
HilleVax
Price$13.99
Change+$0.51 (+3.78%)
Volume$318.17K
CapitalizationN/A
View a ticker or compare two or three
BEAM vs HLVX Comparison Chart

Loading...

BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
HLVXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
BEAM vs. HLVX commentary
May 10, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a StrongBuy and HLVX is a Hold.

COMPARISON
Comparison
May 10, 2024
Stock price -- (BEAM: $22.24 vs. HLVX: $13.48)
Brand notoriety: BEAM and HLVX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 62% vs. HLVX: 27%
Market capitalization -- BEAM: $1.86B vs. HLVX: $690.62M
BEAM [@Biotechnology] is valued at $1.86B. HLVX’s [@Biotechnology] market capitalization is $690.62M. The market cap for tickers in the [@Biotechnology] industry ranges from $567.57B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileHLVX’s FA Score has 1 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • HLVX’s FA Score: 1 green, 4 red.
According to our system of comparison, both BEAM and HLVX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while HLVX’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 3 bearish.
  • HLVX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, HLVX is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +2.30% price change this week, while HLVX (@Biotechnology) price change was -0.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.21%. For the same industry, the average monthly price growth was -4.72%, and the average quarterly price growth was +71.05%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 06, 2024.

HLVX is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+0.21% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for BEAM with price predictions.
OPEN
A.I.dvisor published
a Summary for HLVX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
BEAM($1.86B) has a higher market cap than HLVX($670M). HLVX YTD gains are higher at: -16.012 vs. BEAM (-18.295).
BEAMHLVXBEAM / HLVX
Capitalization1.86B670M277%
EBITDAN/AN/A-
Gain YTD-18.295-16.012114%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
TECHNICAL ANALYSIS
Technical Analysis
BEAMHLVX
RSI
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 7 days ago
81%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 15 days ago
83%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
73%
View a ticker or compare two or three
Ad is loading...
BEAMDaily Signal changed days agoGain/Loss if shorted
 
Show more...
HLVXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BRUEX16.210.05
+0.31%
MFS Blended Research Value Equity B
PEQLX34.480.03
+0.09%
Putnam Large Cap Value R5
VELIX16.52-0.01
-0.06%
VELA Large Cap Plus I
FFAAX14.93-0.01
-0.07%
Franklin Global Allocation Adv
FMFCX95.71-0.46
-0.48%
Fidelity Advisor Materials C

HLVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HLVX has been loosely correlated with PRME. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if HLVX jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HLVX
1D Price
Change %
HLVX100%
-2.95%
PRME - HLVX
38%
Loosely correlated
-3.77%
NTLA - HLVX
36%
Loosely correlated
-3.69%
XNCR - HLVX
35%
Loosely correlated
-2.39%
SCPH - HLVX
35%
Loosely correlated
-4.29%
SVRA - HLVX
34%
Loosely correlated
-5.13%
More